Burke Steven Keith - Insider Non-Derivative Transactions at Akebia Therapeutics, Inc. (AKBA) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Feb 29, 2024, Burke Steven Keith's relationship to Akebia Therapeutics, Inc. (AKBA) is Officer (SVP, Chief Medical Officer), and currently has 695,840 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other AKBA insiders.

Data Source: SEC.
Burke Steven Keith - Insider Non-Derivative Transactions of AKBA Common Stock
Burke Steven Keith - Insider Non-Derivative Transactions at AKBA
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Mar 1, 2024 Sell -- (Common Stock) 7169 1.58 695840
Feb 28, 2024 Sell -- (Common Stock) 8367 1.52 703009
Feb 2, 2024 Sell -- (Common Stock) 24311 1.68 711376
Feb 1, 2024 Acquisition -- (Common Stock) 202200 0 735687
Aug 26, 2023 Sell -- (Common Stock) 27000 1.15 668840
May 17, 2023 Sell -- (Common Stock) 63567 1.07 530487
Mar 2, 2023 Sell -- (Common Stock) 1110 0.88 594054
Mar 2, 2023 Sell -- (Common Stock) 6400 0.88 595164
Mar 2, 2023 Sell -- (Common Stock) 6613 0.88 601564
Feb 28, 2023 Sell -- (Common Stock) 7539 0.81 608177
Feb 1, 2023 Acquisition -- (Common Stock) 196200 0 615716